We are live on ! Find out more
EC

EcoR1 Capital Portfolio holdings

AUM $2.34B
1-Year Est. Return 204.53%
This Fund
S&P 500
This Quarter Est. Return
+13.6%
1 Year Est. Return
+204.53%
3 Year Est. Return
+306.25%
5 Year Est. Return
+490.45%
10 Year Est. Return
+14,115.48%
AUM
$284M
AUM Growth
+$15.8M
Cap. Flow
-$18M
Cap. Flow %
-6.36%
Top 10 Hldgs %
87.41%
Holding
28
New
7
Increased
3
Reduced
2
Closed
5

Top Buys

1
KYNB
Kyntra Bio
KYNB
+$18.7M
2
ATYR
aTyr Pharma
ATYR
+$18.6M
3
EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
+$17.5M
4
COLL icon
Collegium Pharmaceutical
COLL
+$8.04M
5
ARRY
Array Biopharma Inc
ARRY
+$2.95M

Top Sells

1
RCPT
RECEPTOS INC COM STK (DE)
RCPT
+$24.9M
2
CLVS
Clovis Oncology, Inc.
CLVS
+$18M
3
IRWD icon
Ironwood Pharmaceuticals
IRWD
+$14.4M
4
SAGE
Sage Therapeutics
SAGE
+$5.65M
5
FLXN
Flexion Therapeutics, Inc.
FLXN
+$3.67M

Sector Composition

1 Healthcare 77.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ATRA icon
1
Atara Biotherapeutics
ATRA
$76.6M
$56.1M 19.78%
42,528
– –
EPZM
2
DELISTED
Epizyme, Inc
EPZM
$40.5M 14.27%
1,685,800
+105,400
+7% +$2.03M
ASMB icon
3
Assembly Biosciences
ASMB
$532M
$30.3M 10.69%
131,176
– –
KYNB
4
Kyntra Bio
KYNB
$29.8M
$28.3M 9.99%
48,216
+32,216
+201% +$18.7M
KITE
5
DELISTED
Kite Pharma, Inc.
KITE
$17.2M 6.05%
281,400
– –
DCOY
6
Decoy Therapeutics
DCOY
$3.07M
$15.6M 5.51%
1
– –
ATYR
7
aTyr Pharma
ATYR
$53.7M
$15.5M 5.47%
+59,776
New +$18.6M
TVTX icon
8
Travere Therapeutics
TVTX
$5.3B
$11.3M 3.99%
341,650
-68,350
-17% -$1.87M
KIN
9
DELISTED
Kindred Biosciences, Inc.
KIN
$8.83M 3.11%
1,294,431
– –
COLL icon
10
Collegium Pharmaceutical
COLL
$1.17B
$8.3M 2.93%
+465,118
New +$8.04M
FWP
11
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
$6.05M 2.13%
22,712
– –
GNVC
12
DELISTED
GenVec, Inc.
GNVC
$4.05M 1.43%
198,641
– –
EIGR
13
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$3.58M 1.26%
+6,318
New +$17.5M
CALA
14
DELISTED
Calithera Biosciences, Inc
CALA
$2.97M 1.05%
20,774
+6,000
+41% +$1.39M
ARRY
15
DELISTED
Array Biopharma Inc
ARRY
$2.88M 1.02%
+400,000
New +$2.95M
BITI
16
DELISTED
BIOTIE THERAPIES CORP SPONSORED ADR
BITI
$2M 0.7%
+100,000
New +$2.09M
GYRE icon
17
Gyre Therapeutics
GYRE
$735M
$1.73M 0.61%
787
– –
MCRB icon
18
Seres Therapeutics
MCRB
$52M
$1.66M 0.59%
+2,000
New +$1.75M
QLTI
19
DELISTED
QLT Inc
QLTI
$1.65M 0.58%
+400,000
New +$1.54M
XENE icon
20
Xenon Pharmaceuticals
XENE
$6.55B
$842K 0.3%
73,000
-147,570
-67% -$2.04M
IRWD icon
21
Ironwood Pharmaceuticals
IRWD
$658M
– –
-1,074,600
Closed -$14.4M
RGLS
22
DELISTED
Regulus Therapeutics
RGLS
– –
0
– –
SAGE
23
DELISTED
Sage Therapeutics
SAGE
– –
-112,455
Closed -$5.65M
TPST icon
24
Tempest Therapeutics
TPST
$16.9M
– –
0
– –
CLVS
25
DELISTED
Clovis Oncology, Inc.
CLVS
– –
-243,048
Closed -$18M
1
2

Similar funds

G
GenTrust Miami, Florida $2.34B AUM 18.43% 1-Year Est. Return
MC
Moors & Cabot Boston, Massachusetts $2.34B AUM 30.42% 1-Year Est. Return
BAM
Berkshire Asset Management Wilkes Barre, Pennsylvania $2.33B AUM 19.33% 1-Year Est. Return
CC
Capital Counsel New York $2.35B AUM 21.34% 1-Year Est. Return
HFM
Harvest Fund Management Beijing, China $2.35B AUM 49.85% 1-Year Est. Return
NO
Ninety One Cape Town, South Africa $2.33B AUM 92.42% 1-Year Est. Return
ST
Sageworth Trust Lancaster, Pennsylvania $2.33B AUM 20.04% 1-Year Est. Return
MFAM
Motley Fool Asset Management Alexandria, Virginia $2.33B AUM 21.93% 1-Year Est. Return